Magnetic Resonance Imaging of Brain Development in Autism

NCT ID: NCT00449566

Last Updated: 2007-03-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate brain development in autism by longitudinally assessing children with autism, as well as typically developing controls, using advanced MR techniques. We will use longitudinal diffusion tensor imaging (DTI) measures to investigate the protracted development of long-range white matter fibers in autism. In addition, we will investigate the effect of autism risk genes on brain development.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Autism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Aged 6 - 18 years at initial MRI


1\) DSM-IV (APA, 1994) diagnosis of autism, according to ADI-R interview


1. no DSM-IV (APA, 1994) diagnosis, according to DISC interview
2. no scores in the clinical range on the Child Behavior Checklist (CBCL) and Teacher Rating Form (TRF)
3. IQ \> 70

Exclusion Criteria

1. major illness of the cardiovascular, the endocrine, the pulmonal or the gastrointestinal system
2. presence of metal objects in or around the body (pacemaker, dental braces)
3. history of or present neurological disorder
4. for individuals over 12 years of age: legal incompetence, defined as the obvious inability to comprehend the information that is presented by the investigator and is outlined in the Information letter and on which the decision to participate in the study is to be based
Minimum Eligible Age

6 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

UMC Utrecht

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sarah Durston, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht

Herman van Engeland, M.D. Ph.D.

Role: STUDY_CHAIR

Rudolf Magnust Institute of Neuroscience, UMC Utrecht

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dept. of Child and Adolescent Psychiatry, UMC Utrecht

Utrecht, , Netherlands

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sarah Durston

Role: CONTACT

+31 30 250 8161

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marieke Langen, M.Sc.

Role: primary

+31 30 250 7084

References

Explore related publications, articles, or registry entries linked to this study.

Langen M, Durston S, Staal WG, Palmen SJ, van Engeland H. Caudate nucleus is enlarged in high-functioning medication-naive subjects with autism. Biol Psychiatry. 2007 Aug 1;62(3):262-6. doi: 10.1016/j.biopsych.2006.09.040. Epub 2007 Jan 16.

Reference Type BACKGROUND
PMID: 17224135 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.niche-lab.nl

Lab homepage with info for subjects (in Dutch)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

METC 05/208-K

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

NMR Scanning on Patients
NCT00001194 COMPLETED